APA (7th ed.) Citation

B, S., N, D., & M, M. (2024). Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply. Alimentary pharmacology & therapeutics, 60(4), 542. https://doi.org/10.1111/apt.18144

Chicago Style (17th ed.) Citation

B, Scheiner, Dominik N, and Mandorfer M. "Letter: Helicobacter Pylori and Metabolic Syndrome-related Von Willebrand Factor and Plasminogen Activator Inhibitor-1 Activity Levels for Outcome Prediction of Advanced Chronic Liver Disease: Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 4 (2024): 542. https://doi.org/10.1111/apt.18144.

MLA (9th ed.) Citation

B, Scheiner, et al. "Letter: Helicobacter Pylori and Metabolic Syndrome-related Von Willebrand Factor and Plasminogen Activator Inhibitor-1 Activity Levels for Outcome Prediction of Advanced Chronic Liver Disease: Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 4, 2024, p. 542, https://doi.org/10.1111/apt.18144.